Press "Enter" to skip to content

New patent expiration for NOVO drug SAXENDA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for NOVO drug SAXENDA

Annual Drug Patent Expirations for SAXENDA
Annual Drug Patent Expirations for SAXENDA

Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting this drug.

SAXENDA drug price trends.

Drug patent litigation for SAXENDA.

This drug has thirty-eight patent family members in thirteen countries.

The generic ingredient in SAXENDA is liraglutide recombinant. Two suppliers are listed for this compound. Additional details are available on the liraglutide recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for NOVO drug SAXENDA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions